NO20063220L - Tricykliske imidazopyridiner for anvendelse som gastriske sekresjonsinhibitorer - Google Patents

Tricykliske imidazopyridiner for anvendelse som gastriske sekresjonsinhibitorer

Info

Publication number
NO20063220L
NO20063220L NO20063220A NO20063220A NO20063220L NO 20063220 L NO20063220 L NO 20063220L NO 20063220 A NO20063220 A NO 20063220A NO 20063220 A NO20063220 A NO 20063220A NO 20063220 L NO20063220 L NO 20063220L
Authority
NO
Norway
Prior art keywords
gastric secretion
secretion inhibitors
imidazopyridines
tricyclic
tricyclic imidazopyridines
Prior art date
Application number
NO20063220A
Other languages
English (en)
Inventor
Wolfgang-Alexander Simon
Wilm Buhr
Peter Jan Zimmermann
Christof Brehm
Vittoria Chiesa
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of NO20063220L publication Critical patent/NO20063220L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen tilveiebringer forbindelser med formel 1, hvor substituentene og symbolene er som definert i beskrivelsen. Forbindelsene hemmer sekresjonen av magesyre.
NO20063220A 2003-12-19 2006-07-11 Tricykliske imidazopyridiner for anvendelse som gastriske sekresjonsinhibitorer NO20063220L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03029361 2003-12-19
PCT/EP2004/053560 WO2005058325A1 (en) 2003-12-19 2004-12-17 Tricyclic imidazopyridines for use as gastric secretion inhibitors

Publications (1)

Publication Number Publication Date
NO20063220L true NO20063220L (no) 2006-07-11

Family

ID=34684549

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063220A NO20063220L (no) 2003-12-19 2006-07-11 Tricykliske imidazopyridiner for anvendelse som gastriske sekresjonsinhibitorer

Country Status (15)

Country Link
US (1) US20070066674A1 (no)
EP (1) EP1696921A1 (no)
JP (1) JP2007514714A (no)
KR (1) KR20070007041A (no)
CN (1) CN1889955A (no)
AR (1) AR046941A1 (no)
AU (1) AU2004298788A1 (no)
BR (1) BRPI0417263A (no)
CA (1) CA2549030A1 (no)
EA (1) EA200601106A1 (no)
IL (1) IL175724A0 (no)
NO (1) NO20063220L (no)
TW (1) TW200526212A (no)
WO (1) WO2005058325A1 (no)
ZA (1) ZA200604134B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004298453A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
MX2007015087A (es) * 2005-06-22 2008-01-24 Nycomed Gmbh Proceso para la produccion de intermediarios para la preparacion de bencimidazoles triciclicos.
WO2007141253A1 (en) * 2006-06-07 2007-12-13 Nycomed Gmbh Process for the production of intermediates for the preparation of tricyclic imidazopyridines
US8648080B2 (en) 2009-07-09 2014-02-11 Raqualia Pharma Inc. Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
WO2014195333A1 (de) 2013-06-04 2014-12-11 Bayer Pharma Aktiengesellschaft 3-aryl-substituierte imidazo[1,2-a]pyridine und ihre verwendung
CA2939793A1 (en) 2014-02-19 2015-08-27 Bayer Pharma Aktiengesellschaft 3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines
CN107001361A (zh) 2014-12-02 2017-08-01 拜耳医药股份有限公司 杂芳基取代的咪唑并[1，2‑a]吡啶及其用途
CN112500421B (zh) * 2020-12-15 2021-08-24 河南科技大学第一附属医院 一种可用于杀菌消毒的苯并吡喃脲类化合物的制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
JP2004512338A (ja) * 2000-10-25 2004-04-22 アルタナ　ファルマ　アクチエンゲゼルシャフト 胃液分泌抑制剤としてのポリ置換イミダゾピリジン
JP2005504761A (ja) * 2001-08-10 2005-02-17 アルタナ　ファルマ　アクチエンゲゼルシャフト 三環式イミダゾピリジン

Also Published As

Publication number Publication date
WO2005058325A8 (en) 2006-05-11
EP1696921A1 (en) 2006-09-06
AU2004298788A1 (en) 2005-06-30
CA2549030A1 (en) 2005-06-30
US20070066674A1 (en) 2007-03-22
TW200526212A (en) 2005-08-16
IL175724A0 (en) 2006-09-05
JP2007514714A (ja) 2007-06-07
WO2005058325A1 (en) 2005-06-30
BRPI0417263A (pt) 2007-03-06
EA200601106A1 (ru) 2006-12-29
CN1889955A (zh) 2007-01-03
KR20070007041A (ko) 2007-01-12
ZA200604134B (en) 2008-01-30
AR046941A1 (es) 2006-01-04

Similar Documents

Publication Publication Date Title
NO20064632L (no) Tricykliske imidazopyridiner
NO20063220L (no) Tricykliske imidazopyridiner for anvendelse som gastriske sekresjonsinhibitorer
NO20044995L (no) Heterosykliske forbindelser
NO20074666L (no) Imidazo(1,2-A)pyridinforbindelser som VEGF-R2-inhibitorer
NO20064351L (no) Caspaseinhibitorer og anvendelser derav
NO20061789L (no) Aminopyridinderivater som induserbare NO-syntaseinhibitorer
ATE297931T1 (de) Tricyclische imidazopyridine
NO20054199L (no) 6-substituerte imidazopyraziner
NO20052857L (no) 8-substituerte imidazopyridiner
NO20080144L (no) Spiro-benzimidazoler som inhibitorer av magesyre og sekresjon
DE60127131D1 (de) Tricyclische imidazopyridine
EA200300478A1 (ru) Полизамещенные имидазопиридины в качестве ингибиторов желудочной секреции
NO20052994L (no) Nye fosforamidderivater.
TW200600502A (en) Novel 6-substituted benzimidazoles
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
WO2006061380A3 (en) SUBSTITUTED IMIDAZO[4,5-b]PYRIDINES AS INHIBITORS OF GASTRIC ACID SECRETION
WO2005070927A3 (en) 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors
IS8034A (is) Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla
NO20045123L (no) Nitroserte imidazopyridiner
NO20072340L (no) Difluorsubstituerte Imidazopyridiner
WO2008071766A3 (en) Spiro-indene substituted imidazonaphythyridine and pyranoimidazopyridine derivatives as inhibitors of gastric acid secretion
NO20070058L (no) Amino-halogen-imidazopyridiner som protonpumpeinhibitorer
NO20071685L (no) Tricykliske adamantylamidderivater som 11-beta hydroksysteroid-dehydrogenaseinhibitorer
TW200716637A (en) Pharmaceutically active spiro-imidazopyridines

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

FC2A Withdrawal, rejection or dismissal of laid open patent application